Clinical Utility of Cariprazine in the Management of Acute Schizophrenia: Current Evidence and Practical Recommendations
Actas Españolas de Psiquiatría · 15.08.2026 · 54 (4) · 1331-1349
DOI: 10.62641/aep.v54i4.2145 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Actas Españolas de Psiquiatría, online erschienen am 15.08.2026. Verfasst von José Manuel Montes-Rodríguez und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Hospital Universitario Ramón y Cajal, IRYCIS, 28034 Madrid, Spain. Hauptthemen laut MEDLINE: Schizophrenia, Piperazines, Antipsychotic Agents. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The management of schizophrenia in acute care units presents significant challenges, particularly in addressing negative symptoms and functional impairment. Cariprazine, a dopamine D3/D2 receptor partial agonist, offers a unique pharmacological profile in this setting. This review aims to provide an expert consensus on the clinical utility of cariprazine in acute settings and establish practical recommendations for its use.
Methods
A comprehensive literature review was conducted across specialized databases, including PubMed/MEDLINE, EMBASE, PsycINFO, and the Cochrane Library, ensuring a robust evidence base. The consensus was developed by a panel of six senior experts during a formal consensus meeting held in Madrid. Following a structured discussion and evidence synthesis, a modified Delphi-like process was employed to refine the recommendations. The quality of evidence and the strength of the recommendations were assessed using the grading of recommendations assessment, development, and evaluation (GRADE) approach.
Results
The evidence confirms cariprazine’s efficacy in acute exacerbations, with a distinct advantage in treating predominant negative symptoms and hostility compared to other second-generation antipsychotics (SGAs). Its metabolic-neutral profile and D3-mediated impact on craving also make it a strategic option for patients with dual diagnosis.
Conclusions
Cariprazine is a valuable tool for the stabilization and long-term functional recovery of patients in acute psychiatric units. The consensus provides a practical framework to optimize its clinical application based on high-quality evidence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry, Hospital Universitario Ramón y Cajal, IRYCIS, 28034 Madrid, Spain.
- Mental Health Area of Hospital Fundación Hospitalarias Barcelona (Sant Rafael), 08035 Barcelona, Spain.
- Department of Psychiatry, Hospital Universitario Doctor Peset, 46017 Valencia, Spain.
- Department of Medicine, School of Medicine, University of Valencia, 46017 Valencia, Spain.
- Psychiatric Hospitalisation Unit, Hospital Universitario de Navarra, 31008 Pamplona, Navarra, Spain.
- Department of Psychiatry, Hospital Universitario de Badajoz, 06080 Badajoz, Spain.
Zitieren
APA
Montes-Rodríguez, J. M., Collazos-Sánchez, F., Martínez-Raga, J., Blas-Soto, J., Bolivar-Perálvarez, M., & Gutiérrez-Rojas, L. (2026). Clinical Utility of Cariprazine in the Management of Acute Schizophrenia: Current Evidence and Practical Recommendations. Actas Españolas de Psiquiatría, 54(4), 1331-1349. https://doi.org/10.62641/aep.v54i4.2145
Vancouver
Montes-Rodríguez JM, Collazos-Sánchez F, Martínez-Raga J, Blas-Soto J, Bolivar-Perálvarez M, Gutiérrez-Rojas L. Clinical Utility of Cariprazine in the Management of Acute Schizophrenia: Current Evidence and Practical Recommendations. Actas Españolas de Psiquiatría. 2026;54(4):1331-1349. doi:10.62641/aep.v54i4.2145
BibTeX
@article{MontesRodrguez2026,
author = {Montes-Rodríguez, José Manuel and Collazos-Sánchez, Francisco and Martínez-Raga, José and Blas-Soto, José de and Bolivar-Perálvarez, Moisés and Gutiérrez-Rojas, Luis},
title = {Clinical Utility of Cariprazine in the Management of Acute Schizophrenia: Current Evidence and Practical Recommendations},
journal = {Actas Españolas de Psiquiatría},
year = {2026},
volume = {54},
number = {4},
pages = {1331--1349},
doi = {10.62641/aep.v54i4.2145}
}
EUVIMED